Trichinosis differential diagnosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Changes made per Mahshid's request |
||
(3 intermediate revisions by one other user not shown) | |||
Line 10: | Line 10: | ||
|+ '''Differentiating Trichinosis from other Diseases'''<ref name="abc">FAO/WHO/OIE Guidelines for the surveillance, management, prevention and control of trichinellosis. FAO (2007). http://www.fao.org/documents/card/en/c/61e00fb1-87e8-5b89-8be1-50481e43eed1/ Accessed on January 28, 2016 </ref> | |+ '''Differentiating Trichinosis from other Diseases'''<ref name="abc">FAO/WHO/OIE Guidelines for the surveillance, management, prevention and control of trichinellosis. FAO (2007). http://www.fao.org/documents/card/en/c/61e00fb1-87e8-5b89-8be1-50481e43eed1/ Accessed on January 28, 2016 </ref> | ||
! style="width: 180px;background: #4479BA" |{{fontcolor|#FFF| Differential Diagnosis}} | ! style="width: 180px;background: #4479BA" |{{fontcolor|#FFF| Differential Diagnosis}} | ||
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Similar Clinical | ! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Similar Clinical Features}} | ||
! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| | ! style="width: 120px;background: #4479BA" |{{fontcolor|#FFF| Distinguishing Clinical Features}} | ||
|- | |- | ||
| style="width: 120px;font-weight: bold;background: #DCDCDC" | | | style="width: 120px;font-weight: bold;background: #DCDCDC" | | ||
Line 40: | Line 40: | ||
* Invasive Schistosomiasis | * Invasive Schistosomiasis | ||
| style="background: #F5F5F5; text-align:center" | Eosinophilia + fever | | style="background: #F5F5F5; text-align:center" | Eosinophilia + fever | ||
| style="background: #F5F5F5; text-align: | | style="background: #F5F5F5; text-align:left" | | ||
* Fascioliasis: Latent phase after symptoms start | * Fascioliasis: Latent phase after symptoms start | ||
*Toxocariasis: Elevation of anti-A, anti–B isohaemagglutinins | *Toxocariasis: Elevation of anti-A, anti–B isohaemagglutinins | ||
Line 58: | Line 58: | ||
*Periarteritis Nodosa | *Periarteritis Nodosa | ||
| style="background: #F5F5F5; text-align:center" | Periorbital or facial edema + fever | | style="background: #F5F5F5; text-align:center" | Periorbital or facial edema + fever | ||
| style="background: #F5F5F5; text-align: | | style="background: #F5F5F5; text-align:left" | | ||
* Glomerulonephritis: Hematuria | * Glomerulonephritis: Hematuria + foamy urine | ||
*Serum Sickness: Due to an antiserum derived from an animal source | *Serum Sickness: Due to an antiserum derived from an animal source | ||
Line 65: | Line 65: | ||
*Polymyositis: Weakness and/or loss of muscle mass in the proximal musculature + dysphagia + foot drop | *Polymyositis: Weakness and/or loss of muscle mass in the proximal musculature + dysphagia + foot drop | ||
*Dermatomyositis: Symmetric proximal muscle weakness +Gottron's sign + heliotrope + Shawl (or V-) sign + Erythroderma | *Dermatomyositis: Symmetric proximal muscle weakness + Gottron's sign + heliotrope + Shawl (or V-) sign + Erythroderma | ||
*Periarteritis Nodosa: Nodules in the lower legs + nerve | *Periarteritis Nodosa: Nodules in the lower legs + nerve involvement (numbness, pain, burning, and weakness) + Livedo reticularis | ||
|- | |- | ||
| style="width: 120px;font-weight: bold;background: #DCDCDC" | | | style="width: 120px;font-weight: bold;background: #DCDCDC" | | ||
Line 74: | Line 74: | ||
*Bacterial Endocarditis | *Bacterial Endocarditis | ||
| style="background: #F5F5F5; text-align:center" | Haemorrhages of the conjunctiva or haemorrhagic skin petechiae + fever | | style="background: #F5F5F5; text-align:center" | Haemorrhages of the conjunctiva or haemorrhagic skin petechiae + fever | ||
| style="background: #F5F5F5; text-align: | | style="background: #F5F5F5; text-align:left" | | ||
* Leptospirosis: Jaundice + asymptomatic phase (3–4 days) after symptoms start | * Leptospirosis: Jaundice + asymptomatic phase (3–4 days) after symptoms start | ||
Line 82: | Line 82: | ||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
Latest revision as of 19:01, 18 September 2017
Trichinosis Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Trichinosis differential diagnosis On the Web |
American Roentgen Ray Society Images of Trichinosis differential diagnosis |
Risk calculators and risk factors for Trichinosis differential diagnosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac
Overview
Trichinosis must be differentiated from influenza virus, salmonella, shigella, eosinophilia-myalgia syndromes, tissular parasitosis, glomerulonephritis, serum sickness, infectious meningitis and encephalitis, leptospirosis, bacterial endocarditis and typhus exanthematicus.[1]
Differentiating Trichinosis from other Diseases
Differential Diagnosis | Similar Clinical Features | Distinguishing Clinical Features |
---|---|---|
|
High fever + myalgia | No eosinophilia |
|
Protracted diarrhoea | No eosinophilia |
Eosinophilia-Myalgia Syndromes:
|
Eosinophilia + myalgia + inflammatory response | History of L-tryptophan ingestion |
|
Eosinophilia + fever |
|
|
Periorbital or facial edema + fever |
|
|
Haemorrhages of the conjunctiva or haemorrhagic skin petechiae + fever |
|
References
- ↑ 1.0 1.1 FAO/WHO/OIE Guidelines for the surveillance, management, prevention and control of trichinellosis. FAO (2007). http://www.fao.org/documents/card/en/c/61e00fb1-87e8-5b89-8be1-50481e43eed1/ Accessed on January 28, 2016